Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-50
Closed -$8K 673
2018
Q1
$8K Buy
+50
New +$9.72K 0.02% 421
2017
Q4
Sell
-13
Closed -$2K 747
2017
Q3
$2K Hold
13
﹤0.01% 984
2017
Q2
$2K Sell
13
-1,497
-99% -$241K ﹤0.01% 973
2017
Q1
$221K Hold
1,510
0.32% 73
2016
Q4
$201K Hold
1,510
0.33% 70
2016
Q3
$197K Hold
1,510
0.35% 68
2016
Q2
$193K Buy
1,510
+1,461
+2,982% +$193K 0.31% 89
2016
Q1
$7K Hold
49
0.01% 710
2015
Q4
$7K Sell
49
-925
-95% -$127K 0.01% 755
2015
Q3
$132K Buy
974
+923
+1,810% +$134K 0.18% 125
2015
Q2
$8K Sell
51
-922
-95% -$127K 0.01% 769
2015
Q1
$126K Buy
973
+857
+739% +$99.6K 0.15% 144
2014
Q4
$12K Sell
116
-76
-40% -$7.49K 0.01% 683
2014
Q3
$17K Buy
+192
New +$17.9K 0.02% 516

Other funds holding CI

Thompson Davis & Co's CI Position: Q2 2018 in Review

Thompson Davis & Co sold out of Cigna (CI) in Q2 2018, closing a stake of 50 shares — an estimated $8K sold.

Thompson Davis & Co first reported a position in CI in Q3 2014 and held it in 14 quarters. The position peaked at $221K in Q1 2017. 858 funds tracked by Wall St. Rank hold CI as of Q2 2018.

  • Thompson Davis & Co reported no remaining Cigna position as of Q2 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 50 Cigna shares in Q2 2018, an estimated $8K.
  • Thompson Davis & Co first reported a position in Cigna in Q3 2014 and held it in 14 quarters.
  • Thompson Davis & Co's Cigna position peaked at $221K in Q1 2017.
  • 858 funds tracked by Wall St. Rank held Cigna as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.